Berkshire Asset Management LLC Brainstorm Cell Therapeutics Inc. Transaction History

Berkshire Asset Management LLC

  • $2.09 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$3.99 - $17.73 $63,042 - $280,134
-15,800 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$11.19 - $16.92 $176,802 - $267,336
15,800 New
15,800 $267,000

Others Institutions Holding BCLI

# of Institutions
33
Shares Held
10.5M
Call Options Held
160K
Put Options Held
30.5K
View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

BCLI Quotes by TradingView
  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $75.9M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Berkshire Asset Management LLC Portfolio

Follow Berkshire Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email